These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37855038)

  • 21. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis.
    Suzuki T; Matsusaka T; Nakayama M; Asano T; Watanabe T; Ichikawa I; Nagata M
    Am J Pathol; 2009 May; 174(5):1675-82. PubMed ID: 19359523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
    Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
    J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources.
    Kaverina NV; Eng DG; Schneider RR; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1397-413. PubMed ID: 27076646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes.
    Barutta F; Kimura S; Hase K; Bellini S; Corbetta B; Corbelli A; Fiordaliso F; Barreca A; Papotti MG; Ghiggeri GM; Salvidio G; Roccatello D; Audrito V; Deaglio S; Gambino R; Bruno S; Camussi G; Martini M; Hirsch E; Durazzo M; Ohno H; Gruden G
    J Am Soc Nephrol; 2021 May; 32(5):1114-1130. PubMed ID: 33722931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asparagine endopeptidase protects podocytes in adriamycin-induced nephropathy by regulating actin dynamics through cleaving transgelin.
    Qiu Y; Lei C; Zeng J; Xie Y; Cao Y; Yuan Q; Su H; Zhang Z; Zhang C
    Mol Ther; 2023 Nov; 31(11):3337-3354. PubMed ID: 37689970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span.
    Kaverina N; Schweickart RA; Chan GC; Maggiore JC; Eng DG; Zeng Y; McKinzie SR; Perry HS; Ali A; O'Connor C; Pereira BMV; Theberge AB; Vaughan JC; Loretz CJ; Chang A; Hukriede NA; Bitzer M; Pippin JW; Wessely O; Shankland SJ
    Aging (Albany NY); 2023 Jul; 15(14):6658-6689. PubMed ID: 37487005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.
    Liu S; Shi W; Xiao H; Liang X; Deng C; Ye Z; Mei P; Wang S; Liu X; Shan Z; Liang Y; Zhang B; Wang W; Liu Y; Xu L; Xia Y; Ma J; Li Z
    PLoS One; 2012; 7(7):e41331. PubMed ID: 22848465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
    Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis.
    Hu H; Li M; Chen B; Guo C; Yang N
    Clin Exp Nephrol; 2022 Nov; 26(11):1055-1066. PubMed ID: 35925422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of CD44-positive glomerular parietal epithelial cells reflects podocyte injury in adriamycin nephropathy.
    Okamoto T; Sasaki S; Yamazaki T; Sato Y; Ito H; Ariga T
    Nephron Exp Nephrol; 2013; 124(3-4):11-8. PubMed ID: 24401840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.
    Koehler S; Kuczkowski A; Kuehne L; Jüngst C; Hoehne M; Grahammer F; Eddy S; Kretzler M; Beck BB; Höhfeld J; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
    J Am Soc Nephrol; 2020 Mar; 31(3):544-559. PubMed ID: 32047005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.
    Hodgin JB; Bitzer M; Wickman L; Afshinnia F; Wang SQ; O'Connor C; Yang Y; Meadowbrooke C; Chowdhury M; Kikuchi M; Wiggins JE; Wiggins RC
    J Am Soc Nephrol; 2015 Dec; 26(12):3162-78. PubMed ID: 26038526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
    Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
    J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
    Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
    J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.